Delivery Order SPE2DB22D1041-SPE2DB25FUCH7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,224.45 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg on September 16, 2025, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $69,230.76 on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 17, 2025, and represents a routine pharmaceutical procurement within the federal medical supply system. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $6,081.01 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a pharmaceutical product for diabetes management. This competitive award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $1,913.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on August 14, 2025, with completion scheduled for August 15, 2025. This non-set-aside competitive award represents a pharmaceutical delivery under the agency's medical supply procurement operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal healthcare systems and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,417.63 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded delivery order, utilizing firm fixed pricing with no set-aside designation, represents pharmaceutical procurement under AmerisourceBergen's broader supply agreement with the federal government. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $2,293.92 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-500 mg on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order, which is not set-aside, represents a pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $34,839.53. This firm fixed-price delivery order, which is expected to be completed by May 7, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCH7Delivery Order
The Defense Logistics Agency awarded a $19,778.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on September 23, 2025, with an ultimate completion date of September 24, 2025. This non-competitive delivery order is being fulfilled from the contractor's place of business in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically supporting military and veteran healthcare requirements through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains, with delivery orders consistently structured as firm fixed-price arrangements to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 9/23/25 |